Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Verinder Sidhu, Justine M. Naylor, Sam Adie, Durga Bastiras, Rachelle Buchbinder, Ilana Ackerman & Ian A. Harris. (2023) Post‐discharge patient‐reported non‐adherence to aspirin compared to enoxaparin for venous thromboembolism prophylaxis after hip or knee arthroplasty. ANZ Journal of Surgery 93:4, pages 989-994.
Crossref
Crossref
Helen Badge, Tim Churches, Justine M. Naylor, Wei Xuan, Elizabeth Armstrong, Leeanne Gray, John Fletcher, Iain Gosbell, Chung-Wei Christine Lin & Ian A. Harris. (2022) Association between VTE and antibiotic prophylaxis guideline compliance and patient-reported outcomes after total hip and knee arthroplasty: an observational study. Journal of Patient-Reported Outcomes 6:1.
Crossref
Crossref
Leandra Marla Aires Travassos Viana, Iara Antônia Lustosa Nogueira, Andréa Martins Melo Fontenele & Liszt Palmeira de Oliveira. (2021) Tromboembolismo na artroplastia: Adesão à profilaxia. Revista Brasileira de Ortopedia 56:05, pages 647-655.
Crossref
Crossref
F. Todd, D. Yeomans, M.R. Whitehouse & G.S. Matharu. (2021) Does venous thromboembolism prophylaxis affect the risk of venous thromboembolism and adverse events following primary hip and knee replacement? A retrospective cohort study. Journal of Orthopaedics 25, pages 301-304.
Crossref
Crossref
Harry T Mai, Taif Mukhdomi, Daniel Croxford, Patricia Apruzzese, Mark C Kendall & Gildasio S De Oliveira. (2021) Safety and outcomes of outpatient compared to inpatient total knee arthroplasty: a national retrospective cohort study. Regional Anesthesia & Pain Medicine 46:1, pages 13-17.
Crossref
Crossref
Olivier Q. Groot, Paul T. Ogink, Nuno Rei Paulino Pereira, Marco L. Ferrone, Mitchell B. Harris, Santiago A. Lozano-Calderon, Andrew J. Schoenfeld & Joseph H. Schwab. (2019) High Risk of Symptomatic Venous Thromboembolism After Surgery for Spine Metastatic Bone Lesions: A Retrospective Study. Clinical Orthopaedics & Related Research 477:7, pages 1674-1686.
Crossref
Crossref
M. Farzan Rashid, Terri L. Jackson, Jheanell A. Morgan, Franklin A. Dwyer, Beth A. Schrope, John A. Chabot & Michael D. Kluger. (2018) Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer. Journal of Gastrointestinal Surgery 23:6, pages 1166-1171.
Crossref
Crossref
Brian Hallstrom. (2019) Which Aspirin to Choose?—Reply. JAMA Surgery 154:6, pages 565.
Crossref
Crossref
Guangwei Sun, Jingjing Wu, Qian Wang, Qiang Liang, Jian Jia, Kai Cheng, Guoliang Sun & Zili Wang. (2019) Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. The Journal of Arthroplasty 34:4, pages 789-800.e6.
Crossref
Crossref
Xin Lu & Jin Lin. (2018) Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. BMC Musculoskeletal Disorders 19:1.
Crossref
Crossref
Olivier Q. Groot, Paul T. Ogink, Stein J. Janssen, Nuno Rui Paulino Pereira, Santiago Lozano-Calderon, Kevin Raskin, Francis Hornicek & Joseph H. Schwab. (2018) High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients. Clinical Orthopaedics & Related Research 476:10, pages 2052-2061.
Crossref
Crossref
Sunyoung Kim, Hongyup Ahn, Soon-ae Shin, Jong-heon Park & Chang Won Won. (2017) Trends of thromboprophylaxis and complications after major lower limb orthopaedic surgeries in Korea: National Health Insurance Claim Data. Thrombosis Research 155, pages 48-52.
Crossref
Crossref
Alexandre Caron, Emmanuel Chazard, Joris Muller, Renaud Perichon, Laurie Ferret, Vassilis Koutkias, Régis Beuscart, Jean-Baptiste Beuscart & Grégoire Ficheur. (2017) IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety. Journal of the American Medical Informatics Association 24:2, pages 323-330.
Crossref
Crossref
Madeline Lemke, Kaitlyn Beyfuss, Julie Hallet, Natalie G. Coburn, Calvin H. L. Law & Paul J. Karanicolas. (2016) Patient Adherence and Experience with Extended Use of Prophylactic Low-Molecular-Weight Heparin Following Pancreas and Liver Resection. Journal of Gastrointestinal Surgery 20:12, pages 1986-1996.
Crossref
Crossref
Chun-Ja KimElizabeth A. SchlenkJeong-Ah AhnMoonsun KimEunyoung ParkJeeWon Park. (2016) Evaluation of the Measurement Properties of Self-reported Medication Adherence Instruments Among People at Risk for Metabolic Syndrome. The Diabetes Educator 42:5, pages 618-634.
Crossref
Crossref
Ian Litchfield, David Fitzmaurice, Patricia Apenteng, Sian Harrison, Carl Heneghan, Alison Ward & Sheila Greenfield. (2016) Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study. British Journal of General Practice 66:649, pages e593-e602.
Crossref
Crossref
Simon Frostick. (2016) Pharmacological thromboprophylaxis and total hip or knee replacement. British Journal of Nursing 25:1, pages 45-53.
Crossref
Crossref
Rosanna Abbate, Maddalena Pazzi, Lorenza Rossi & Gabriele Cioni. 2015. Perioperative Medical Management for Total Joint Arthroplasty. Perioperative Medical Management for Total Joint Arthroplasty
51
60
.
Toby Trujillo & Paul P. Dobesh. (2014) Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications. Drugs 74:14, pages 1587-1603.
Crossref
Crossref
Andrew D. Carrothers, Sebastian R. Rodriguez-Elizalde, Benedict A. Rogers, Helen Razmjou, Jeffrey D. Gollish & John J. Murnaghan. (2014) Patient-Reported Compliance with Thromboprophylaxis Using an Oral Factor Xa Inhibitor (Rivaroxaban) Following Total Hip and Total Knee Arthroplasty. The Journal of Arthroplasty 29:7, pages 1463-1467.
Crossref
Crossref
Paul P. Dobesh. (2013) Economic Implications of Inadequate Treatment of Venous Thromboembolism and Potential Solutions. Journal of Pharmacy Practice 27:2, pages 178-186.
Crossref
Crossref
Axel C. Matzdorff & David Green. (2014) Management of venous thromboembolism in cancer patients. Reviews in Vascular Medicine 2:1, pages 24-36.
Crossref
Crossref
Youn-Soo ParkSeung-Jae LimTaehun Lee. (2014) Prevention of Venous Thromboembolism in Hip Surgery Patients. Hip & Pelvis 26:1, pages 1.
Crossref
Crossref
MARY OLADEJO & SUSAN BEWLEY. (2012) ADHERENCE IN PREGNANCY: A SYSTEMATIC REVIEW OF THE LITERATURE. Fetal and Maternal Medicine Review 23:3-4, pages 201-229.
Crossref
Crossref
Emma D. Deeks. (2012) Apixaban. Drugs 72:9, pages 1271-1291.
Crossref
Crossref
Yngve Falck-Ytter, Charles W. Francis, Norman A. Johanson, Catherine Curley, Ola E. Dahl, Sam Schulman, Thomas L. Ortel, Stephen G. Pauker & Clifford W. ColwellJrJr. (2012) Prevention of VTE in Orthopedic Surgery Patients. Chest 141:2, pages e278S-e325S.
Crossref
Crossref
Ann K. Wittkowsky. (2012) Novel Oral Anticoagulants and Their Role in Clinical Practice. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:12, pages 1175-1191.
Crossref
Crossref